GTx (Pharmaceuticals) Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 139

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $26M

GTx (Pharmaceuticals) General Information

Description

GTx Inc is a biopharmaceutical company. It is involved in the business of discovery, development, and commercialization of small molecules for the treatment of cancer including treatment of breast and prostate cancer and other serious medical conditions such as Stress urinary incontinence and Duchenne muscular dystrophy. Its lead product candidate is Enobosarm. The company's strategy is focused on the further development of selective androgen receptor modulators.

Contact Information

Website
www.gtxinc.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 175 Toyota Plaza
  • 7th Floor
  • Memphis, TN 38103
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 175 Toyota Plaza
  • 7th Floor
  • Memphis, TN 38103
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GTx (Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 07-Jun-2019 $26M Completed Generating Revenue
7. Secondary Transaction - Open Market 26-Sep-2018 Completed Generating Revenue
6. PIPE 28-Sep-2017 Completed Generating Revenue
5. PIPE 24-Nov-2014 Completed Generating Revenue
4. Grant 03-Nov-2010 Completed Generating Revenue
3. IPO 03-Feb-2004 Completed Generating Revenue
2. Later Stage VC (Series E) 20-Aug-2003 $20M $20M Completed Product Development
1. Early Stage VC 13-Oct-2002 Completed Startup
To view GTx (Pharmaceuticals)’s complete valuation and funding history, request access »

GTx (Pharmaceuticals) Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E
Series D
Series C
Series B2
Series B
Series A2 140,000 $0.001000 $7.28 $7.28 1x $57.66 0.18%
Series A 200,000 $0.001000 8% $7.28 $7.28 1x $7.28 2.02%
To view GTx (Pharmaceuticals)’s complete cap table history, request access »

GTx (Pharmaceuticals) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
GTx Inc is a biopharmaceutical company. It is involved in the business of discovery, development, and commercialization
Drug Discovery
Memphis, TN
139 As of 2008

Cambridge, MA
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GTx (Pharmaceuticals) Competitors (40)

One of GTx (Pharmaceuticals)’s 40 competitors is Sarepta Therapeutics, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sarepta Therapeutics Formerly VC-backed Cambridge, MA
Pliant Therapeutics Formerly VC-backed San Francisco, CA
Exelixis Formerly VC-backed Alameda, CA
Kyntra Bio Formerly VC-backed San Francisco, CA
Monopar Therapeutics Formerly VC-backed Wilmette, IL
You’re viewing 5 of 40 competitors. Get the full list »

GTx (Pharmaceuticals) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GTx (Pharmaceuticals) Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aisling Capital Venture Capital Minority
Amzak Capital Management Family Office Minority
BVF Partners Hedge Fund Minority
MB Venture Partners Venture Capital Minority
Oracle Investment Management Hedge Fund Minority
You’re viewing 5 of 7 investors. Get the full list »

GTx (Pharmaceuticals) Acquisitions (1)

GTx (Pharmaceuticals)’s most recent deal was a Reverse Merger with Oncternal Therapeutics. The deal was made on 07-Jun-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Oncternal Therapeutics 07-Jun-2019 Reverse Merger Drug Discovery
To view GTx (Pharmaceuticals)’s complete acquisitions history, request access »

GTx (Pharmaceuticals) FAQs

  • When was GTx (Pharmaceuticals) founded?

    GTx (Pharmaceuticals) was founded in 1997.

  • Where is GTx (Pharmaceuticals) headquartered?

    GTx (Pharmaceuticals) is headquartered in Memphis, TN.

  • What is the size of GTx (Pharmaceuticals)?

    GTx (Pharmaceuticals) has 139 total employees.

  • What industry is GTx (Pharmaceuticals) in?

    GTx (Pharmaceuticals)’s primary industry is Drug Discovery.

  • Is GTx (Pharmaceuticals) a private or public company?

    GTx (Pharmaceuticals) is a Private company.

  • What is the current valuation of GTx (Pharmaceuticals)?

    The current valuation of GTx (Pharmaceuticals) is .

  • What is GTx (Pharmaceuticals)’s current revenue?

    The current revenue for GTx (Pharmaceuticals) is .

  • How much funding has GTx (Pharmaceuticals) raised over time?

    GTx (Pharmaceuticals) has raised $190M.

  • Who are GTx (Pharmaceuticals)’s investors?

    Aisling Capital, Amzak Capital Management, BVF Partners, MB Venture Partners, and Oracle Investment Management are 5 of 7 investors who have invested in GTx (Pharmaceuticals).

  • Who are GTx (Pharmaceuticals)’s competitors?

    Sarepta Therapeutics, Pliant Therapeutics, Exelixis, Kyntra Bio, and Monopar Therapeutics are some of the 40 competitors of GTx (Pharmaceuticals).

  • When was GTx (Pharmaceuticals) acquired?

    GTx (Pharmaceuticals) was acquired on 07-Jun-2019.

  • Who acquired GTx (Pharmaceuticals)?

    GTx (Pharmaceuticals) was acquired by Oncternal Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process